29
Inflammatory Inflammatory Glaucoma Glaucoma Dr.Ashraful Huq Dr.Ashraful Huq FCPS FCPS Eye Specialist & Surgeon Eye Specialist & Surgeon Bangladesh Eye Bangladesh Eye Hospital Ltd. Hospital Ltd. [email protected] [email protected]

Inflm. glaucoma

Embed Size (px)

Citation preview

Page 1: Inflm. glaucoma

Inflammatory Glaucoma Inflammatory Glaucoma

Dr.Ashraful HuqDr.Ashraful Huq FCPSFCPS

Eye Specialist & SurgeonEye Specialist & Surgeon Bangladesh Eye Hospital Ltd.Bangladesh Eye Hospital Ltd.

[email protected]@gmail.com

Page 2: Inflm. glaucoma

Definition Definition

Inflammatory glaucoma is a condition in whichInflammatory glaucoma is a condition in whichocular inflammation causes -ocular inflammation causes - a persistent or recurrent IOP elevationa persistent or recurrent IOP elevation resulting in progressive optic nerve cuppingresulting in progressive optic nerve cupping with corresponding neuro retinal rim loss with corresponding neuro retinal rim loss and/ or development of typical,perimetric, and/ or development of typical,perimetric,

glaucomatous field defect.glaucomatous field defect.

It presents a diagnostic & therapeutic challenge.It presents a diagnostic & therapeutic challenge.

Page 3: Inflm. glaucoma

MajorMajor ocular inflammation associated ocular inflammation associated with secondary glaucomawith secondary glaucoma

Posner-Schlossman syndromePosner-Schlossman syndrome Fuch’s Heterochromic IridocyclitisFuch’s Heterochromic Iridocyclitis Juvenile Rheumatiod ArthritisJuvenile Rheumatiod Arthritis SarcoidosisSarcoidosis Herpes Simplex Kerato-uveitisHerpes Simplex Kerato-uveitis Vericella Zoster IridocyclitisVericella Zoster Iridocyclitis Syphilis Syphilis Vogt-Koyanagi-Harada SyndromeVogt-Koyanagi-Harada Syndrome Toxoplasma RetinitisToxoplasma Retinitis Scleritis & EpiscleritisScleritis & Episcleritis

Page 4: Inflm. glaucoma

Diagnostic dilemmas Diagnostic dilemmas

Fluctuation of IOPFluctuation of IOP Ciliary body shutdown Ciliary body shutdown Uncertain mechanism of raised IOP Uncertain mechanism of raised IOP Assessment of glaucomatous damage Assessment of glaucomatous damage

Presence of iris vesselsPresence of iris vessels

Page 5: Inflm. glaucoma

Classification Classification

Angle-closure with pupillary blockAngle-closure with pupillary block Angle-closure without pupillary blockAngle-closure without pupillary block Open angleOpen angle Posner-Schlossman syndromePosner-Schlossman syndrome

Page 6: Inflm. glaucoma

Secondary angle closure with Secondary angle closure with pupillary blockpupillary block

Pathogenesis-Pathogenesis-

Posterior synechiae → 360° iridolenticular Posterior synechiae → 360° iridolenticular

adhesion(seclusio pupillae) → Iris bombe adhesion(seclusio pupillae) → Iris bombe → shallow anterior chamber and → shallow anterior chamber and apposition of the iris to the trabeculum & apposition of the iris to the trabeculum & peripheral cornea → iridocorneal contact peripheral cornea → iridocorneal contact becomes permanent → development of becomes permanent → development of PAS.PAS.

Page 7: Inflm. glaucoma
Page 8: Inflm. glaucoma

Findings Findings

Slit lamp bio-microscopy - Slit lamp bio-microscopy - Seclusio pupillaeSeclusio pupillae Iris bombeIris bombe Shallow A/C Shallow A/C Gonioscopy – Gonioscopy – Angle closure from irido-trabecular contactAngle closure from irido-trabecular contact Indentation gonioscopy – Indentation gonioscopy – Extent of appositionExtent of apposition

Page 9: Inflm. glaucoma

Management Management

Prevention of posterior synechiae & Prevention of posterior synechiae & seclusio pupillae - seclusio pupillae -

Atropine 1%Atropine 1% Tropicamide 1%Tropicamide 1% Mydriatics.Mydriatics. Prevention of synechial angle closure - Prevention of synechial angle closure - Intensive topical steroids Intensive topical steroids Sub-Tenon triamcinolone acetonide.Sub-Tenon triamcinolone acetonide.

Page 10: Inflm. glaucoma

Management Management (continued)(continued)

Lowering of IOP – Lowering of IOP –

Topical aqueous suppressant : beta-Topical aqueous suppressant : beta-blocker, CAI , Hyper osmotic agents.blocker, CAI , Hyper osmotic agents.

Surgery – Surgery –

Laser iridotomyLaser iridotomy

Surgical iridectomy.Surgical iridectomy.

Page 11: Inflm. glaucoma

Secondary angle closure without Secondary angle closure without pupillary blockpupillary block

Pathogenesis- Pathogenesis-

Chronic anterior uveitis →deposition and Chronic anterior uveitis →deposition and contraction of inflammatory debris in the contraction of inflammatory debris in the angle → pulling of peripheral iris over the angle → pulling of peripheral iris over the trabeculum → gradual & progressive trabeculum → gradual & progressive synechial angle closure.synechial angle closure.

Page 12: Inflm. glaucoma

Risk factors Risk factors

Eyes with pre-existing narrow angleEyes with pre-existing narrow angle

Eyes with granulomatous inflammation Eyes with granulomatous inflammation with inflammatory nodules in the anglewith inflammatory nodules in the angle

Page 13: Inflm. glaucoma

Findings Findings

Deep A/CDeep A/C Extensive angle closure by PAS on Extensive angle closure by PAS on

gonioscopygonioscopy Raised IOPRaised IOP Optic nerve head changeOptic nerve head change

Page 14: Inflm. glaucoma

Management Management

Prevention – Prevention –

Reconstitution of A/CReconstitution of A/C

Good medical control of pre existing Good medical control of pre existing uveitisuveitis

Observation in mild uveitisObservation in mild uveitis

Page 15: Inflm. glaucoma

Management Management (continued)(continued)

Medical management -Medical management -

Topical aqueous suppressant : beta-Topical aqueous suppressant : beta-blocker, CAI, Hyperosmotic agents.blocker, CAI, Hyperosmotic agents.

Invasive procedure – Invasive procedure –

Trabeculectomy with anti metabolite, Trabeculectomy with anti metabolite, Trabeculo dialysis, Trabeculo dialysis,

Artificial drainage shunts,Artificial drainage shunts,

Cyclo destructive procedure.Cyclo destructive procedure.

Page 16: Inflm. glaucoma

Inflammatory open angle glaucomaInflammatory open angle glaucoma

Pathogenesis - Pathogenesis - Trabecular obstruction by inflammatory Trabecular obstruction by inflammatory

cells and debris causing increased cells and debris causing increased aqueous viscosity.aqueous viscosity.

Acute trabeculitis causing inflammation Acute trabeculitis causing inflammation and edema of trabecular meshwork → and edema of trabecular meshwork → reduction in meshwork pore size reduction in meshwork pore size →Glaucoma. →Glaucoma.

Page 17: Inflm. glaucoma

Pathogenesis – Pathogenesis – (continued)(continued)

Hypersecretion by Prostaglandins.Hypersecretion by Prostaglandins. Trabecular scarring/sclerosis secondary Trabecular scarring/sclerosis secondary

to chronic trabeculitis in chronic anterior to chronic trabeculitis in chronic anterior uveitis.uveitis.

Page 18: Inflm. glaucoma

Clinical features Clinical features

Raised IOPRaised IOP Flares and cellsFlares and cells Posterior synechiaePosterior synechiae Keratic precipitates (KP)Keratic precipitates (KP) Irregular small pupilIrregular small pupil Mashed potato like Mashed potato like

membrane in the membrane in the trabeculumtrabeculum

Page 19: Inflm. glaucoma

Management Management

IOP comes down to normal once uveitis is IOP comes down to normal once uveitis is cured. cured.

Topical steroids are to be applied.Topical steroids are to be applied.

Page 20: Inflm. glaucoma

Posner-Schlossman SyndromePosner-Schlossman Syndrome

Also called glaucomatocyclitic crisisAlso called glaucomatocyclitic crisis RecurrentRecurrent UnilateralUnilateral Acute secondary open angle glaucoma Acute secondary open angle glaucoma

associated with mild anterior uveitisassociated with mild anterior uveitis Herpes simplex virus may play a Herpes simplex virus may play a

pathogenic rolepathogenic role

Page 21: Inflm. glaucoma

Posner-Schlossman Syndrome Posner-Schlossman Syndrome (continued)(continued)

Rare condition Rare condition Affecting young adultsAffecting young adults 40% of whom are HLA-Bw54 positive40% of whom are HLA-Bw54 positive Male > FemaleMale > Female 50% patients have bilateral involvement at 50% patients have bilateral involvement at

different time.different time. A significant percentage will develop A significant percentage will develop

chronic open-angle glaucoma.chronic open-angle glaucoma.

Page 22: Inflm. glaucoma

►►Presentation –Presentation –

mild discomfortmild discomfort

haloes around lightshaloes around lights

slight blurring of visionslight blurring of vision

►►Gonioscopy – Gonioscopy –

Open angle.Open angle.

► ►Slit-lamp Slit-lamp

biomicroscopy – biomicroscopy –

corneal epithelial corneal epithelial oedema,oedema,

High IOP (40-80 High IOP (40-80 mmHg),mmHg),

Few aqueous cells,Few aqueous cells,

Fine white central Fine white central keratic precipitates.keratic precipitates.

Page 23: Inflm. glaucoma

Management Management

During acute attack- Topical steroid, During acute attack- Topical steroid, Aqueous suppressant.Aqueous suppressant.

Oral non-steroidal anti-inflammatory Oral non-steroidal anti-inflammatory agents(indomethacin).agents(indomethacin).

Page 24: Inflm. glaucoma

Fuchs’ uveitis syndromeFuchs’ uveitis syndrome

Idiopathic, painlessIdiopathic, painless Chronic, low-grade iridocyclitis with Chronic, low-grade iridocyclitis with

heterochromia,due to iris stromal atrophyheterochromia,due to iris stromal atrophy CataractCataract The typical age of onset is 20 - 40 years of The typical age of onset is 20 - 40 years of

ageage Men and women affected equallyMen and women affected equally It is typically unilateral, but in 13% of the It is typically unilateral, but in 13% of the

cases it has presented bilaterallycases it has presented bilaterally

Page 25: Inflm. glaucoma

Findings Findings

Slit lamp bio-microscopy – Slit lamp bio-microscopy –

A. small ,round or stellete gray-white A. small ,round or stellete gray-white

scattered KP. scattered KP.

B.Faint flare & few cells,no synechiae. B.Faint flare & few cells,no synechiae.

C.Diffuse iris stromal C.Diffuse iris stromal

atrophy,Heterochromia. atrophy,Heterochromia.

D. Rubeosis,enlarged pupil, vitritis.D. Rubeosis,enlarged pupil, vitritis.

Page 26: Inflm. glaucoma

Gonioscopy – Gonioscopy –

A. Normal angle A. Normal angle

B. Neo-vascularization B. Neo-vascularization

C. Occationally an abnormal C. Occationally an abnormal

membrane over the angle membrane over the angle

D. Small,non confluent, irregular D. Small,non confluent, irregular

PAS.PAS.

Page 27: Inflm. glaucoma

Management Management

Topical glaucoma medication.Topical glaucoma medication.

Invasive procedure with anti-metabolite.Invasive procedure with anti-metabolite.

Page 28: Inflm. glaucoma

Points to remember in medical Points to remember in medical treatmenttreatment

Steroids are absolutely necessary.Steroids are absolutely necessary. Treat the inflammation first and the IOP Treat the inflammation first and the IOP

secondarily.secondarily. Strong cycloplegia is necessary. Strong cycloplegia is necessary. Avoid pilocarpine and other miotics –as it induce Avoid pilocarpine and other miotics –as it induce

ciliary spasm and increase inflammation.ciliary spasm and increase inflammation. Avoid the prostaglandin analog –Avoid the prostaglandin analog – as in any inflammatory condition, there will as in any inflammatory condition, there will

already be copious amounts of prostaglandins in already be copious amounts of prostaglandins in the anterior chamber.the anterior chamber.

Page 29: Inflm. glaucoma

Thank you